Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zhengyuan Huo"'
Publikováno v:
International Journal of Clinical Practice, Vol 2024 (2024)
Background. Gliomas are primary malignant tumors of the central nervous system. The TEA domain transcription factor (TEAD) family proteins are the ultimate effector molecules of the Hippo pathway. However, their expression and function in gliomas hav
Externí odkaz:
https://doaj.org/article/2ec38c51ea684a70b6e004a10c3731ac
Autor:
Hui Huang, Zhengyuan Huo, Jiantong Jiao, Wei Ji, Jin Huang, Zheng Bian, Bin Xu, Junfei Shao, Jun Sun
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Gliomas are the most common primary malignant tumours of the central nervous system (CNS). To improve the prognosis of glioma, it is necessary to identify molecular markers that may be useful for glioma therapy. HOXC6, an importan
Externí odkaz:
https://doaj.org/article/1a48aafb94a34e348996d05f27eb3098
Publikováno v:
International Journal of Clinical Practice, Vol 2023 (2023)
Immunogenic cell death (ICD) regulators exert a crucial part in quite a few in numerous biological processes. This study aimed to determine the function and diagnostic value of ICD regulators in acute ischemic stroke (AIS). 31 significant ICD regulat
Externí odkaz:
https://doaj.org/article/40b17f3fce4c418fb8374b8eed1101df
Autor:
Zheng Bian, Wei Ji, Bin Xu, Zhengyuan Huo, Hui Huang, Jin Huang, Jiantong Jiao, Junfei Shao, Xiaolu Zhang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Glioma is the most common malignant primary brain tumour in adults. Despite improvements in neurosurgery and radiotherapy, the prognosis of glioma patients remains poor. One of the main limitations is that there are no proper clinical therap
Externí odkaz:
https://doaj.org/article/03396c3c365741488f84d3ed523ec40a
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background The epidermal growth factor receptor (EGFR) family belongs to the transmembrane protein receptor of the tyrosine kinase I subfamily and has 4 members: EGFR/ERBB1, ERBB2, ERBB3, and ERBB4. The EGFR family is closely related to the
Externí odkaz:
https://doaj.org/article/67acf713b52043d596c2f6f93c20b698
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Cancer
BMC Cancer
BackgroundThe epidermal growth factor receptor (EGFR) family belongs to the transmembrane protein receptor of the tyrosine kinase I subfamily and has 4 members: EGFR/ERBB1, ERBB2, ERBB3, and ERBB4. The EGFR family is closely related to the occurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584824d449eaf3cf71845edb02a12254
https://doaj.org/article/67acf713b52043d596c2f6f93c20b698
https://doaj.org/article/67acf713b52043d596c2f6f93c20b698
Autor:
Zhengyuan Huo, Jin Huang, Xiaolu Zhang, Junfei Shao, Hui Huang, Wei Ji, Jiantong Jiao, Zheng Bian, Bin Xu
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Glioma is the most common malignant primary brain tumour in adults. Despite improvements in neurosurgery and radiotherapy, the prognosis of glioma patients remains poor. One of the main limitations is that there are no proper clinical therapeutic tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b465379d4bd1b3953b7cbc19ab88d6ca
https://doi.org/10.1186/s12935-021-02144-y
https://doi.org/10.1186/s12935-021-02144-y
Background: Epidermal growth factor receptor (EGFR) family belongs to the transmembrane protein receptor of tyrosine kinase I subfamily, including 4 members, they are EGFR/ERBB1, ERBB2, ERBB3, ERBB4. The EGFR family is closely related to the occurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eb0360f31b74ebc620bc72e6fe8a4b1
https://doi.org/10.21203/rs.3.rs-144472/v1
https://doi.org/10.21203/rs.3.rs-144472/v1
Autor:
Zheng Bian, Jie Mei, Xiaoqing Li, Wei Ji, Jun Sun, Bin Xu, Zhengyuan Huo, Jiantong Jiao, Junfei Shao
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 134, Iss, Pp 111115-(2021)
Glioblastoma (GBM) is the most common primary malignant tumor in adults, and its morbidity and mortality are very high. Although progress has been achieved in the treatment of GBM, such as surgery, chemotherapy and radiotherapy, in recent years, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7d971b8d9b755714cd71d70e6dc26e
https://doi.org/10.1016/j.biopha.2020.111115
https://doi.org/10.1016/j.biopha.2020.111115